Skip to main content
Premium Trial:

Request an Annual Quote

Waters Enters Credit Agreement for $1.4B in Debt Financing

NEW YORK (GenomeWeb News) – Waters has entered into a new credit agreement to provide the company $1.4 billion in debt financing.

In a document filed today with the US Securities and Exchange Commission, Waters said that the credit agreement, dated June 25, is with JP Morgan Chase Bank as administrative agent and JP Morgan Europe as London agent. It provides Waters with a five-year unsecured $300 million term loan facility and a $1.1 billion revolving facility, which includes a letter of credit and a swingline subfacility.

Waters may request the lending group to increase its commitments by at least $25 million from time to time for an aggregate additional amount of $200 million, it said. The term loan facility and revolving facilities mature on June 25, 2018.

Waters said that it has borrowed $300 million under the term loan facility and $560 million under the revolving facility. The $860 million was used to repay the outstanding amounts under its previous credit agreement entered into in July 2011 with a maturity date of July 28, 2016.

JP Morgan Chase Bank served as administrative agent and JP Morgan Europe was the London agent on the earlier credit agreement, which provided for a $300 million term loan facility and a $900 million revolving facility, including a letter of credit and a swingline subfacility.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.